tiprankstipranks

Sanjay Chanda Insider Profile

4 Followers
Sanjay Chanda, SVP, Drug Development at Anacor Pharmaceuticals, holds 28.23K shares in AN2 Therapeutics, Inc. (Ticker: ANTX), holds 29.09K shares in Anacor Pharmaceuticals (Ticker: ~ANAC).
tipranks
Sanjay Chanda

Sanjay Chanda
Anacor Pharmaceuticals (~ANAC)
SVP, Drug Development

Not Ranked
Sanjay Chanda has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$65K
100.00%
A breakdown of Sanjay Chanda's holdings

Insider Roles

AN2 Therapeutics, Inc.
(ANTX)
CDO
Roles that Sanjay Chanda holds in companies

Most Profitable Insider Trade

Stock:
Anacor Pharmaceuticals
(~ANAC)
Rating:Informative Buy
Date:Dec 22, 2014 - Dec 22, 2015
Return:+210.40%
The most profitable trade made by Sanjay Chanda

Sanjay Chanda's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~ANAC
Anacor Pharmaceuticals
Mar 04, 2015
Uninformative Sell
225.00K
$2.88M
AN2 Therapeutics, Inc.
Mar 18, 2024
CDO
Uninformative Buy
$65.22K
List of latest transactions for each holding click on a transaction to see Sanjay Chanda's performance on stock

Sanjay Chanda insider profile FAQ

What is the percentage of profitable transactions made by Sanjay Chanda?
The percentage of profitable transactions made by Sanjay Chanda is ―.
    What is the average return per transaction made by Sanjay Chanda?
    The average return per transaction made by Sanjay Chanda is ―.
      What stocks does Sanjay Chanda hold?
      Sanjay Chanda holds: ~ANAC, ANTX stocks.
        What was Sanjay Chanda’s latest transaction?
        Sanjay Chanda latest transaction was an Uninformative Buy of ―.
          What was Sanjay Chanda's most profitable transaction?
          Sanjay Chanda’s most profitable transaction was an Informative Buy of ~ANAC stock on December 22, 2014. The return on the trade was 210.40%.
            What is Sanjay Chanda's role in Anacor Pharmaceuticals?
            Sanjay Chanda's role in Anacor Pharmaceuticals is SVP, Drug Development.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.